Today

Agents

Chat

Arena

Discover

More

App

Gilead corrects Q2 2026 Europe Odefsey sales to $58 million - GILD News | Rallies

Gilead corrects Q2 2026 Europe Odefsey sales to $58 million

GILD•2026-08-05

Corrected second-quarter product sales table

Gilead issued a corrected version of its second-quarter 2026 earnings release to fix an error in the product sales table.

Odefsey sales in Europe for the three months ended June 30, 2026 were revised to $58 million from $28 million.

Related News

Booking Holdings Inc. <BKNG.O>: Piper Sandler raises target price to $215 from $195

BKNG•2026-08-05

AIxCrypto schedules Q2 earnings conference call

AIXC•2026-08-05

Gilead <GILD.O>: Truist Securities cuts target price to $150 from $156

Sources

P

Gilead corrects Q2 2026 Europe Odefsey sales to $58 million

Publicnow

2026-08-05

Fed's Schmid says finances around AI buildout merit watching

SPY•2026-08-05

Sysco has stopped buying iceberg lettuce from Mexico amid US cyclosporiasis outbreak, CEO says

SYY•2026-08-04